ARCHIVES

Wistar Investigators Report Oncogene Relation to Burkitt’s

This article is from The Cancer Letter archive.

Vol. 08 No. 46 | November 26, 1982

Download PDF Visit The Full Archive

Related Articles

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007